25 records – page 1 of 2.

Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use

https://policybase.cma.ca/link/policy14443
Date
2021-06-24
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health

Health Canada consultation on reducing youth access and appeal of vaping products

https://policybase.cma.ca/link/policy14078
Date
2019-05-24
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health

Health Canada consultation on edible cannabis, extracts & topicals

https://policybase.cma.ca/link/policy14020
Date
2019-02-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health

Health Canada consultation on Canadian drugs and substances strategy

https://policybase.cma.ca/link/policy14017
Date
2018-12-04
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health

Implementation of National Pharmacare

https://policybase.cma.ca/link/policy13933
Date
2018-10-02
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada consultation on tobacco products regulations (plain and standardized appearance)

https://policybase.cma.ca/link/policy13930
Date
2018-09-06
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Support life-saving supervised consumption and overdose prevention sites: open letter to Premier Doug Ford and Health Minister Christine Elliott

https://policybase.cma.ca/link/policy13931
Date
2018-08-30
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada consultation on regulatory amendments regarding tramadol

https://policybase.cma.ca/link/policy13927
Date
2018-08-14
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada consultation on restriction of marketing and advertising of opioids

https://policybase.cma.ca/link/policy13921
Date
2018-07-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on proposed front-of-package labelling

https://policybase.cma.ca/link/policy13882
Date
2018-04-23
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Proposed approach to the regulation of cannabis

https://policybase.cma.ca/link/policy13838
Date
2018-01-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Excise duty framework for cannabis products

https://policybase.cma.ca/link/policy13799
Date
2017-12-07
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Non-prescription availability of low-dose codeine products

https://policybase.cma.ca/link/policy13734
Date
2017-11-7
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA response to patented medicines regulations consultations

https://policybase.cma.ca/link/policy13690
Date
2017-06-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/link/policy13726
Date
2017-05-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/link/policy13802
Date
2016-10-31
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/link/policy11954
Date
2016-08-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/link/policy13817
Date
2016-08-12
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/link/policy11847
Date
2016-03-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs

25 records – page 1 of 2.